Marc Bissonnette

6.4k total citations · 1 hit paper
123 papers, 4.9k citations indexed

About

Marc Bissonnette is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Marc Bissonnette has authored 123 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 43 papers in Pathology and Forensic Medicine and 41 papers in Oncology. Recurrent topics in Marc Bissonnette's work include Vitamin D Research Studies (23 papers), Genetic factors in colorectal cancer (20 papers) and Inflammatory mediators and NSAID effects (14 papers). Marc Bissonnette is often cited by papers focused on Vitamin D Research Studies (23 papers), Genetic factors in colorectal cancer (20 papers) and Inflammatory mediators and NSAID effects (14 papers). Marc Bissonnette collaborates with scholars based in United States, China and Canada. Marc Bissonnette's co-authors include Yan Chun Li, John Hart, Sharad Khare, Thomas A. Brasitus, Mark W. Musch, Urszula Dougherty, Juan Kong, Jun Sun, Reba Mustafi and Ramesh K. Wali and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Marc Bissonnette

120 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier

2007 531 citations Juan Kong, Mark W. Musch et al. profile →

Peers

Countries citing papers authored by Marc Bissonnette

Since Specialization

Citations

This map shows the geographic impact of Marc Bissonnette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Bissonnette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Bissonnette more than expected).

Fields of papers citing papers by Marc Bissonnette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Bissonnette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Bissonnette. The network helps show where Marc Bissonnette may publish in the future.

Co-authorship network of co-authors of Marc Bissonnette

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Bissonnette. A scholar is included among the top collaborators of Marc Bissonnette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Bissonnette. Marc Bissonnette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	YTHDF2 regulates self non-coding RNA metabolism to control inflammation and tumorigenesis 2025 ·Nature Communications ·Seungwon Yang, Yan‐Hong Cui, Haixia Li, Jiangbo Wei, Gayoung Park, Ming Sun, Michelle Verghese, Emma Wilkinson, Tae Gyu Nam, (unknown), Xiao‐Long Cui, Tae Young Ryu, Jing Chen, Marc Bissonnette, Chuan He, Yu‐Ying He	0
2	5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial 2024 ·JCO Precision Oncology ·Diana C. West-Szymanski, Zhou Zhang, Xiaolong Cui, Krissana Kowitwanich, (unknown), (unknown), Urszula Dougherty, Craig Williams, (unknown), Chuan He, Wei Zhang, Marc Bissonnette	1
3	PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines 2023 ·Database ·(unknown), Zhou Zhang, Xiaolong Cui, Chang Zeng, (unknown), Jiajun Cai, Kai Wu, Xu Zhang, Yi‐Xiang Shi, Zoe Arvanitakis, Marc Bissonnette, Brian C.‐H. Chiu, Shi‐Yuan Cheng, Chuan He, Wei Zhang	4
4	Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers 2021 ·Cells ·(unknown), Shuai Zeng, Zhen Lyu, Wei Zhang, Xu Zhang, Urszula Dougherty, Reba Mustafi, Qiong Zhang, Trupti Joshi, Marc Bissonnette, Samrat Roy Choudhury, Sharad Khare	4
5	A New Model of Spontaneous Colitis in Mice Induced by Deletion of an RNA m6A Methyltransferase Component METTL14 in T Cells 2020 ·Cellular and Molecular Gastroenterology and Hepatology ·Thomas X. Lu, Zhong Zheng, Linda Zhang, Hui‐Lung Sun, Marc Bissonnette, Haochu Huang, Chuan He	104
6	Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer 2020 ·Cancers ·(unknown), Wei Zhang, Xu Zhang, Shuai Zeng, Urszula Dougherty, Reba Mustafi, Qiong Zhang, (unknown), Tushar Khare, Trupti Joshi, Diana C. West-Szymanski, Marc Bissonnette, Sharad Khare	15
7	Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer 2019 ·Cancer Prevention Research ·Urszula Dougherty, Reba Mustafi, (unknown), (unknown), Jeffrey S. Souris, Loren Joseph, John Hart, Vani J. Konda, Wei Zhang, Joel Pekow, Yan Chun Li, Marc Bissonnette	3
8	miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD 2017 ·Clinical Cancer Research ·Joel Pekow, Katherine Meckel, Urszula Dougherty, Yong Huang, Xindi Chen, (unknown), Reba Mustafi, (unknown), Zifeng Deng, (unknown), John Hart, David T. Rubin, John H. Kwon, Marc Bissonnette	72
9	ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer 2016 ·Clinical Cancer Research ·Reba Mustafi, Urszula Dougherty, Devkumar Mustafi, (unknown), (unknown), Sarbani Adhikari, (unknown), Katherine Meckel, (unknown), (unknown), Joel Pekow, Vani J. Konda, Loren Joseph, John Hart, Alessandro Fichera, Yan Chun Li, Marc Bissonnette	36
10	The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon 2015 ·Gut ·Wesley A. Grimm, Jeannette S. Messer, Stephen F. Murphy, (unknown), James P. Lodolce, Christopher R. Weber, (unknown), Sarah Bartulis, Brooke E. Sylvester, Amanda Springer, Urszula Dougherty, Timothy B. Niewold, Sonia S. Kupfer, Nathan A. Ellis, Dezheng Huo, Marc Bissonnette, David L. Boone	71
11	The Renin–Angiotensin System Mediates EGF Receptor–Vitamin D Receptor Cross-Talk in Colitis-Associated Colon Cancer 2014 ·Clinical Cancer Research ·Urszula Dougherty, Reba Mustafi, (unknown), (unknown), Devkumar Mustafi, (unknown), (unknown), Weicheng Liu, Vani J. Konda, Joel Pekow, Sharad Khare, John Hart, Loren Joseph, Alice M. Wyrwicz, Gregory S. Karczmar, Yan Chun Li, Marc Bissonnette	36
12	Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis 2013 ·Journal of Clinical Investigation ·Weicheng Liu, Yunzi Chen, Maya Aharoni Golan, Maria Laura Annunziata, Jie Du, Urszula Dougherty, Juan Kong, Mark W. Musch, Yong Huang, Joel Pekow, Chang-Qing Zheng, Marc Bissonnette, Stephen B. Hanauer, Yan Chun Li	268
13	Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions 2013 ·Inflammatory Bowel Diseases ·Joel Pekow, Urszula Dougherty, Yong Huang, (unknown), (unknown), Greg Cohen, Shawn Levy, Masha Kocherginsky, Nanda Venu, Maria Westerhoff, John Hart, Amy Noffsinger, Stephen B. Hanauer, Roger D. Hurst, Alessandro Fichera, Loren Joseph, Qiang Liu, Marc Bissonnette	39
14	EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators 2011 ·Molecular Cancer Research ·(unknown), Urszula Dougherty, Victoria Robinson, Reba Mustafi, Joel Pekow, Sonia S. Kupfer, Yan-Chun Li, John Hart, Kathleen H. Goss, Alessandro Fichera, Loren Joseph, Marc Bissonnette	96
15	Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated Neoplasia 2011 ·American Journal Of Pathology ·Chun‐Chuan Chen, Joel Pekow, Victoria Lladó, (unknown), (unknown), Atsushi Mizoguchi, Mari Mino–Kenudson, Marc Bissonnette, Emiko Mizoguchi	73
16	Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2 2009 ·Clinical Cancer Research ·Urszula Dougherty, (unknown), (unknown), Masha Kocherginsky, (unknown), (unknown), (unknown), Amikar Sehdev, Sandra Cerda, Reba Mustafi, Jorge Delgado, Loren Joseph, Hongyan Zhu, John Hart, David W. Threadgill, Alessandro Fichera, Marc Bissonnette	30
17	Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model 2008 ·Clinical Cancer Research ·Urszula Dougherty, Amikar Sehdev, Sandra Cerda, Reba Mustafi, (unknown), Weihua Yuan, Sujatha Jagadeeswaran, (unknown), Jorge Delgado, Maria Tretiakova, Loren Joseph, John Hart, Ezra E.W. Cohen, (unknown), Alessandro Fichera, Marc Bissonnette	48
18	Epidermal Growth Factor Receptor Signaling Is Required for Microadenoma Formation in the Mouse Azoxymethane Model of Colonic Carcinogenesis 2007 ·Cancer Research ·Alessandro Fichera, (unknown), Sujatha Jagadeeswaran, Urszula Dougherty, Amikar Sehdev, Reba Mustafi, Sandra Cerda, Weihua Yuan, Sharad Khare, Maria Tretiakova, Can Gong, (unknown), Greg Cohen, Loren Joseph, John Hart, Jerrold R. Turner, Marc Bissonnette	47
19	Epidermal Growth Factor Receptor Signaling Is Up-regulated in Human Colonic Aberrant Crypt Foci 2006 ·Cancer Research ·Greg Cohen, Reba Mustafi, (unknown), (unknown), (unknown), Sandra Cerda, Sujatha Jagadeeswaran, Urszula Dougherty, Loren Joseph, John Hart, Lisa Yerian, Maria Tretiakova, Weihua Yuan, Piotr Obara, Sharad Khare, Frank A. Sinicrope, Alessandro Fichera, Gerry R. Boss, Robert E. Carroll, Marc Bissonnette	45
20	Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. 2002 ·PubMed ·Ramesh K. Wali, (unknown), Lan Nguyễn, John Hart, Michael D. Sitrin, Thomas A. Brasitus, Marc Bissonnette	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact